FDA Inspection 949776 — Beyond Technology Corporation Nanchang

Beyond Technology Corporation Nanchang — FEI 3006512913

The FDA completed an inspection of Beyond Technology Corporation Nanchang on November 11, 2015 in Nanchang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 13 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 11, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Nanchang (China)

Citations

IDCFRDescription
109821 CFR 211.22(c)Approve or reject procedures or specs
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
116221 CFR 211.28(a)Protective Apparel Not Worn
136121 CFR 211.100(a)Absence of Written Procedures
187921 CFR 211.180(c)Records not made readily available to FDA
191421 CFR 211.166(a)Lack of written stability program
200821 CFR 211.186(a)Written procedures followed
354521 CFR 211.44Adequate lighting not provided
355721 CFR 211.52Washing and toilet facilities are deficient
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
357321 CFR 211.101(b)Measured components for manufacturing
430321 CFR 211.67(b)Written procedures fail to include